Jeff Childers’s Take

Just days after Pfizer’s CEO swore that a fourth booster would be “necessary” to get back to normal, the Jerusalem Post reported yesterday on a new Israeli study in an article headlined, “Fourth vaccine offers little protection against COVID-19.” Whoops! That’s not good for business.

The study, published by The New England Journal of Medicine, examines the efficacy of the fourth coronavirus vaccine from Pfizer and Moderna. The interim results released show that the vaccine offers little to no protection against contracting the virus when compared to young and healthy individuals vaccinated with three doses.

“Among the approximate 600 participants, 270 of whom received either a fourth dose of the Pfizer vaccine or Moderna vaccine, we found no differences, both in terms of IgG antibody levels and in terms of neutralizing antibody levels, which reached a level similar to that measured a month after the third dose was administered,” explained head researcher Gili Regev-Yochay.

Interestingly, the article was picked up and reprinted by many corporate media outlets including MSN, Today Online, and ABC News. The timing is probably just coincidental, but it makes you think. Anyway, SOMEBODY doesn’t know what they’re talking about, Pfizer or these Israeli researchers. Which do you want to bet on?

? Pfizer’s fourth-booster plans took another hit yesterday, when the CDC’s timorous Director said the agency is broke and can’t afford to buy fourth booster shots, plus she accidentally left her wallet in her other purse from when she went out the other night. So she can’t pay for them anyway.

Thursday, Bloomberg ran a story headlined “Fourth Covid Shots Will Require More Funds, CDC’s Walenksy Says.” See? It’s a setup; it will all be those crafty Republicans’ fault. They’ll be the ones who thwarted jab lovers by obstinately refusing to approve a budget for boosters. You know those Republicans; they’re the WORST. (Don’t get me started on why these people who love jabs so much can’t buy the drugs for themselves.)

Like me, Bloomberg’s reporter noticed that “the White House continues to caution that its Covid funds are running dry … one day after Pfizer-BioNTech asked the FDA to authorize a second booster for Americans 65 and older.” If you read between the headlines, you can see Pfizer and the CDC negotiating. In other words, Pfizer opened the bidding earlier this week saying, we really enjoyed our last deal, and now we want to sell you guys fourth boosters for everybody. Yesterday the CDC responded saying, we can’t afford that, it’s too expensive.

Pfizer’s move!